RI
EPIX

RTW Investments’s ESSA Pharma EPIX Stock Holding History

RTW Investments’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,113,002
Closed -$1.99M – 71
2024
Q4 		$1.99M Sell
1,113,002
-2,148,494
-66% -$6.84M 0.03% 67
2024
Q3 		$19.8M Buy
3,261,496
+962,834
+42% +$5.29M 0.29% 45
2024
Q2 		$12.1M Hold
2,298,662
– – 0.19% 48
2024
Q1 		$19.5M Hold
2,298,662
– – 0.29% 48
2023
Q4 		$15.2M Buy
+2,298,662
New +$11.3M 0.24% 47
2022
Q4 		– Sell
-1,311,294
Closed -$2.39M – 78
2022
Q3 		$2.39M Sell
1,311,294
-1,325,898
-50% -$3.49M 0.06% 80
2022
Q2 		$8.31M Hold
2,637,192
– – 0.21% 67
2022
Q1 		$16.3M Hold
2,637,192
– – 0.34% 57
2021
Q4 		$37.4M Hold
2,637,192
– – 0.55% 53
2021
Q3 		$21.1M Sell
2,637,192
-416,727
-14% -$6.63M 0.32% 61
2021
Q2 		$87.3M Buy
3,053,919
+2,770,227
+976% +$80.5M 1.32% 24
2021
Q1 		$8.24M Buy
+283,692
New +$6.59M 0.13% 77

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $133M AUM 42.18% 1-Year Est. Return

RTW Investments's EPIX Position: Q1 2025 in Review

RTW Investments sold out of ESSA Pharma (EPIX) in Q1 2025, closing a stake of 1,113,002 shares — an estimated $1.99M sold.

RTW Investments first reported a position in EPIX in Q1 2021 and held it in 12 quarters. The position peaked at $87.3M in Q2 2021. 36 funds tracked by Wall St. Rank hold EPIX as of Q1 2025.

  • RTW Investments reported no remaining ESSA Pharma position as of Q1 2025 after selling out during the quarter.
  • RTW Investments sold 1,113,002 ESSA Pharma shares in Q1 2025, an estimated $1.99M.
  • RTW Investments first reported a position in ESSA Pharma in Q1 2021 and held it in 12 quarters.
  • RTW Investments's ESSA Pharma position peaked at $87.3M in Q2 2021.
  • 36 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2025.

Based on RTW Investments's 13F filing for Q1 2025, filed 15 May 2025.